In their first joint appearance since Joe Biden withdrew from the Presidential race to be replaced on the Democrat ticket by Kamala Harris, the duo celebrated the long sought-after Medicare
The US government has published the finalised 'maximum fair prices' (MFPs) for the first 10 medicines subject to Medicare negotiations under the Inflation Reduction Act (IRA), shortly after
Johnson & Johnson has three of its top-selling drugs in Medicare pricing negotiations – Stelara, Xarelto, and Imbruvica – but has said it does not expect a major hit to its finances nex
A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the dig
A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting
The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity under Medicare.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.